Gefitinib-geftinat (250 mg Tablets)

NATCO PHARMA LIMITED (INDIA)

“Gefitinib” is the Drug / Molecule content in “Geftinat”. Gefitinib is an anilinoquinazoline. It attaches to epidermal growth factor receptors (EGFRs), thereby blocking the attachment of EGF and the activation of tyrosine kinase. It targets the mutant protein in the cancerous cells and destroys them.

Category:

Indication

Gefitinib is used for the treatment of Non-Small Cell Lung Cancer.

Note

SCHEDULE H PRESCRIPTION DRUG – CAUTION

To be supplied on the prescription of a Cancer Specialist / Institution / Hospital only. 

Precaution

  • Geftinat is a prescription drug and should be used under proper medical guidance and advice.
  • Contraindicated in pregnancy and lactation.

Related products